供货周期: | 现货 |
品牌: | 康朗生物 |
规格: | 50ug/100ug/250ug |
货号: | KL150Hu01 |
CAS号: |
癌胚抗原(CEA)重组蛋白
来源原核表达
宿主E.coli
内毒素水平<1.0EU/μg(LAL法测定)
亚细胞定位n/a
预测分子量16.0kDa
实际分子量-(差异分析请参阅说明书)
片段与标签Pro93~Val221 (Accession # P06731) with N-terminal His Tag
缓冲液成份磷酸盐缓冲液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
性状冻干粉
纯度> 95%
等电点-
癌胚抗原(CEA)重组蛋白应用SDS-PAGE; WB; ELISA; IP
Carcinoembryonic Antigen (CEA)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
9th Edition (Revised in Jul, 2013)
[ PROPERTIES ]
Residues: Pro93~Val221 (Accession # P06731),
with N-terminal His-Tag.
Host: E. coli
Subcellular Location: Cell membrane;
Lipid-anchor, GPI-anchor. Purity: >95%
Endotoxin Level: <1.0EU per 1μg
(determined by the LAL method).
Formulation: Supplied as lyophilized form in PBS,
pH7.4, containing 5% sucrose, 0.01% sarcosyl.
Predicted isoelectric point: 5.7
Predicted Molecular Mass: 16.0kDa
Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
[ USAGE ]
Reconstitute in sterile PBS, pH7.2-pH7.4.
癌胚抗原(CEA)重组蛋白[ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
precipitation were observed. (Referring from China Biological Products Standard,
which was calculated by the Arrhenius equation.) The loss of this protein is less
than 5% within the expiration date under appropriate storage condition.
癌胚抗原(CEA)重组蛋白[ SEQUENCES ]
The target protein is fused with N-terminal His-Tag, its sequence is listed below.
MGHHHHHHSGSEF- PAYSGREI IYPNASLLIQ NIIQNDTGFY TLHVIKSDLV NEEATGQFRV
YPELPKPSIS SNNSKPVEDK DAVAFTCEPE TQDATYLWWV NNQSLPVSPR LQLSNGNRTL
TLFNVTRNDT ASYKCETQNP V
[ REFERENCES ]
1. Mittal A., et al. (2012) Asian Pac. J. Cancer Prev. 13:275-277.
2. Liu Z.P., et al. (2012) Onkologie 35:108-113.
3. Kim Y.J., et al. (2012) Clin. Chim. Acta 413:511-515.
4. Saeland E., et al. (2012) Int. J. Cancer 131:117-128.
相关产品
关注
拨打电话
留言咨询